FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
UBS maintained a Sell rating on Clorox (NYSE: CLX), and cut the price target to $111.00 (from $118.00), following the company's 1Q earnings report. CLX missed EPS, reporting $1.36 compared to consensus of $1.42. CLX lowered FY17 EPS guidance to $5.23-$5.43 (from $5.38-$5.58 prior).
Analyst Stephen Powers... More
Clorox (NYSE: CLX) reported Q1 EPS of $1.36, $0.06 worse than the analyst estimate of $1.42. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.43 billion.
GUIDANCE:
Clorox maintains sees FY2017 excluding ASU EPS of $5.13-$5.28,... More

